DCF — ADVENTIST MEDICAL CENTER-PORTLAND
Enterprise Value: $-697.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-697.4M
Enterprise Value
$-217.2M
PV of Cash Flows
$-480.2M
PV of Terminal Value
$-773.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $334.0M | $-45.3M | -14.0% | $-59.5M | $-54.1M |
| Year 2 | $344.0M | $-43.2M | -13.0% | $-57.8M | $-47.8M |
| Year 3 | $354.4M | $-41.0M | -12.0% | $-56.0M | $-42.1M |
| Year 4 | $365.0M | $-40.4M | -11.0% | $-55.9M | $-38.1M |
| Year 5 | $375.9M | $-40.7M | -11.0% | $-56.6M | $-35.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-697.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$324.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14069007831109986
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5